Europe Insulin Pens Market Size- By Product Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
Europe Insulin Pens Market Introduction and Overview
According to SPER market research, ‘Europe Insulin Pens Market Size- By Product Type – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’state that the Europe Insulin Pens Market is predicted to reach USD 2.29 Billion by 2033 with a CAGR of 2.1%.
Insulin pens are devices that allow diabetics to deliver insulin in a simple and efficient manner. They are made up of an insulin cartridge, a disposable needle, and a pen-like device that allows users to dial in their desired dosage. Insulin pens exist in two varieties: reusable pens, which may be refilled with insulin cartridges, and disposable pens, which are pre-filled and discarded after use.
The COVID-19 pandemic has had a substantial impact on the European Insulin Pens Market, notably on Type 1 diabetes patients who are more susceptible to severe consequences. Manufacturers, in partnership with local governments, ensured that diabetic patients received insulin devices throughout the pandemic. Medical professionals encourage greater blood glucose monitoring to successfully manage diabetes, which has resulted in an increase in the use of insulin pens.
Scope of the Report:Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Product Type
Regions covered France, Germany, Italy, Russia, Spain, United Kingdom, Rest of Europe
Companies CoveredBiocon, Eli Lilly, Medtronic, Novo Nordisk, Sanofi, Wockhardt, Others
Europe Insulin Pens Market Segmentation:By Product Type:Based on the Product Type, Europe Insulin Pens Market is segmented as; Cartridges in Reusable Pens, Disposable Insulin Pens.
By Region:This research also includes data for France, Germany, Italy, Russia, Spain, United Kingdom, Rest of Europe.